PROTAGONIST THERAPEUTICS INC's ticker is and the CUSIP is 74366E902. A total of 4 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $110,880 | +447.5% | 3,200 | +357.1% | 0.00% | – |
| Q1 2024 | $20,251 | -99.1% | 700 | -99.3% | 0.00% | -100.0% |
| Q4 2023 | $2,272,363 | +36.9% | 99,100 | -0.4% | 0.01% | 0.0% |
| Q3 2023 | $1,659,660 | -44.4% | 99,500 | -8.0% | 0.01% | -40.0% |
| Q2 2023 | $2,985,722 | -11.8% | 108,100 | -26.6% | 0.01% | -16.7% |
| Q1 2023 | $3,385,600 | +586.6% | 147,200 | +225.7% | 0.01% | +1100.0% |
| Q4 2022 | $493,132 | -6.1% | 45,200 | -27.4% | 0.00% | 0.0% |
| Q3 2022 | $525,000 | -34.1% | 62,300 | -38.1% | 0.00% | 0.0% |
| Q2 2022 | $797,000 | -69.3% | 100,700 | -8.3% | 0.00% | -66.7% |
| Q1 2022 | $2,600,000 | -64.9% | 109,800 | -49.3% | 0.00% | -50.0% |
| Q4 2021 | $7,411,000 | +4807.9% | 216,700 | +2449.4% | 0.01% | – |
| Q3 2021 | $151,000 | +1577.8% | 8,500 | +4150.0% | 0.00% | – |
| Q2 2021 | $9,000 | -88.5% | 200 | -33.3% | 0.00% | – |
| Q1 2021 | $78,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING LLC | 147,200 | $3,385,600 | 0.01% |
| SIMPLEX TRADING, LLC | 93,400 | $2,148 | 0.00% |
| JANE STREET GROUP, LLC | 137,400 | $3,160,200 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |